WeVote

Bill

Bill

HB 830

Boards and Commissions - As enacted, changes the qualifications for membership on the medical cannabis commission to include a patient caregiver and a subject matter expert with knowledge of how cannabis is cultivated, processed, shipped, distributed, or prescribed for medical use; specifies that the recommendations made by the commission to the general assembly may include policy recommendations. - Amends TCA Title 4 and Title 68, Chapter 7.

114th Regular Session (2025-2026) Introduced by Bryan Terry

Tennessee law now requires its medical cannabis commission include a patient caregiver and cultivation/distribution expert while explicitly allowing policy recommendations to legislators.

Comp. became Pub. Ch. 209
0
WeVote Research Nonpartisan
Bill Summary · HB 830

Legislative bill overview

HB 830 modifies the composition of Tennessee's medical cannabis commission by requiring membership to include a patient caregiver and a subject matter expert in cannabis cultivation, processing, distribution, or prescription. It also explicitly authorizes the commission to provide policy recommendations to the legislature, not just administrative guidance.

Why is this important

As Tennessee develops its medical cannabis program, the commission's composition directly influences which voices shape regulation and policy. Adding a patient caregiver ensures end-user perspectives are represented, while the cultivation/distribution expert brings practical industry knowledge. The explicit authorization for policy recommendations gives the commission greater influence over future legislative decisions.

Potential points of contention

  • Patient representation balance: Whether one caregiver seat adequately represents diverse patient populations, or if it creates an impression of disproportionate patient influence over industry regulation
  • Industry expertise definition: Ambiguity about what qualifies as sufficient "knowledge" of cultivation/distribution and whether this favors existing operators over new market entrants
  • Commission scope creep: Whether explicitly authorizing policy recommendations expands the commission's influence beyond technical advisory capacity, potentially bypassing standard legislative processes for cannabis-related decisions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.